Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Exchange Rate Effect (2016 - 2025)

Protalix BioTherapeutics has reported Exchange Rate Effect over the past 16 years, most recently at -$31000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$31000.0 for Q4 2025, down 157.41% from a year ago — trailing twelve months through Dec 2025 was -$47000.0 (down 288.0% YoY), and the annual figure for FY2025 was -$47000.0, down 288.0%.
  • Exchange Rate Effect for Q4 2025 was -$31000.0 at Protalix BioTherapeutics, down from -$12000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for PLX hit a ceiling of $54000.0 in Q4 2024 and a floor of -$42000.0 in Q1 2023.
  • Median Exchange Rate Effect over the past 5 years was -$11000.0 (2022), compared with a mean of -$10894.7.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 900.0% in 2022 and later soared 300.0% in 2024.
  • Protalix BioTherapeutics' Exchange Rate Effect stood at $40000.0 in 2021, then plummeted by 165.0% to -$26000.0 in 2022, then dropped by 3.85% to -$27000.0 in 2023, then soared by 300.0% to $54000.0 in 2024, then tumbled by 157.41% to -$31000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$31000.0 (Q4 2025), -$12000.0 (Q3 2025), and $4000.0 (Q2 2025) per Business Quant data.